Blood-thinning medication linked to slower cognitive decline
People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline.
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.